Latest Announcements

Greaves Cotton Ltd reported a 31% growth in consolidated revenue for Q1 FY 2027, driven by disciplined execution across its diversified businesses, and strengthened its international footprint with the incorporation of Greaves International Trading FZE in Dubai, UAE.

RHI Magnesita India Ltd has announced the launch of MINPRO, a joint venture with Khemka Refractories Pvt. Ltd. for refractory recycling and circular mineral solutions in India. MINPRO will operate under the brand MINPRO and will be led by Jyotirmoy Bhattacharjee as CEO. The joint venture aims to increase the availability of high-value circular minerals for refractory production and other industrial applications.

TTK Prestige Ltd's Chairman's Speech at the 70th Annual General Meeting highlights the company's resilience and growth in FY 2025-26, driven by strong domestic demand, sustained government investment, and a gradual recovery in private sector investment. The company reported a 9.6% growth in total revenue to ₹2,773 Crores, with domestic sales rising to ₹2,704 Crores, up by 9.8%. The industry witnessed steady growth, supported by resilient domestic demand, increasing urbanisation, and evolving consumer preferences.

Suzlon Energy Ltd reported Q1 FY27 earnings, with a strong start to the year despite geopolitical tensions in the Middle East. The company delivered 506 MW of installations, its highest ever first quarter, and has a healthy order book of 6.1 GW. The successful launch of the S175 turbine and the Blue Sky Platform marks Suzlon's return to advanced global markets.

Alembic Pharmaceuticals Limited reported its consolidated financial results for the first quarter and year ended 30th June 2026, with revenue from operations increasing by 26% YoY to Rs.2150 Cr. Profit After Tax at Rs. 173 Cr, up 12% YoY, and EBITDA pre R&D increased to Rs. 523 Cr; margin stood at 24%. The company reported robust growth in India Branded Business, US Formulation, and API Business.

Graphite India Ltd has released unaudited financial results for the quarter ended 30th June, 2026, with a profit of ₹157 crore and earnings per share of ₹8.02. The company's revenue from operations was ₹765 crore, and it reported a profit before tax of ₹198 crore. The results have been reviewed by the Audit Committee and approved by the Board.

Alembic Pharmaceuticals Ltd announced its unaudited financial results for Q1 FY27, with revenue increasing by 26% YoY to INR 21.50 Bn, driven by 49% YoY growth in US Formulation and 33% YoY growth in API. EBITDA margin improved to ~24%, with a 7% YoY growth in EBITDA before R&D. The company reported a 33% YoY growth in PAT to INR 1.73 Bn, supported by a strong order book.

Regis Industries Ltd announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a net profit of Rs. 197.68 lakhs and an EPS of Rs. 0.08. The company's revenue from operations was Rs. 583.23 lakhs, with a cost of materials consumed of Rs. 375.69 lakhs. The board of directors approved the financial results at their meeting held on August 4, 2026.

Emami Ltd reports 15% topline growth, with domestic business growing 20% and international business declining 12% due to West Asia disruptions. The company delivered a strong quarter despite external headwinds, with EBITDA growing 6% to ₹226 crore and Profit Before Tax growing 4% to ₹195 crore.

Repro India Ltd reported a 20% YoY growth in consolidated Q1 FY27 revenue, reaching Rs 141 cr, the highest quarterly revenue in its history. The company's digital biz vertical grew by 11% YoY, with the platform vertical growing by 24% YoY to Rs 74 cr, reaching an annualized run-rate of Rs 300 cr. The company has reported an exceptional gain of Rs 167 cr on account of income received from Mahape land sale.

Graphite India Ltd has announced unaudited financial results for the quarter ended 30th June, 2026. The company reported a profit of ₹157 crore, with earnings per share (EPS) at ₹8.02. Revenue from operations was ₹765 crore, and total expenses were ₹674 crore. The company's segment revenue was ₹765 crore, with Graphite and Carbon segment contributing ₹651 crore. The company's total assets were ₹7,228 crore, and total liabilities were ₹1,437 crore.

Emami Ltd reported a 15% growth in consolidated revenues to ₹1,039 crore for the quarter ended June 2026, driven by a 20% growth in domestic business. EBITDA grew 6% to ₹226 crore despite higher input costs. The company made strategic investments in Axiom Ayurveda and IncNut, and remains optimistic about its growth prospects.

Capillary Technologies India Ltd has acquired the CustomerGlu software platform and associated intellectual property from Marax AI, Inc. to redefine the next generation of AI-powered loyalty and customer engagement.

Patel Retail Limited has announced the expansion of its 'Indian Chaska' distribution network with entry into Madhya Pradesh, strengthening its domestic market. The company's flagship brand is now available across 8 States and 1 Union Territory.

Morepen Laboratories Ltd reported its highest-ever quarterly revenue and earnings in Q1 FY27, with EBITDA growing by 207% and PAT by 394%. The company's CDMO mandate entered full scale commercialization phase, with Rs. 58 Cr worth of commercial CDMO dispatches already completed during the quarter.

Dr. Agarwal's Health Care Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.

Indian Metals & Ferro Alloys Ltd (IMFA) has reported record revenue and robust financial performance in Q1 FY27, driven by higher volumes and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, and all four furnaces at KNR 2 are operational. IMFA has also signed a long-term offtake arrangement for additional 65 MWp hybrid renewable energy and is nearing completion of its ethanol project.

Morepen Laboratories Ltd has released its Q1 FY 27 Investor Presentation, highlighting a 34% YoY increase in revenue, 207% YoY increase in EBITDA, and 394% YoY increase in PAT. The company attributes this performance to operational execution and commercial validation of its Morepen 2.0 strategy.

Dr. Agarwal's Health Care Ltd has announced its unaudited consolidated financial results for Q1 FY2027, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores. The company has also announced the appointment of new auditors, internal auditors, and cost auditors, and the incorporation of a wholly owned subsidiary in Nigeria.

Capillary Technologies India Ltd reported strong revenue growth of 43% year-on-year for the quarter ended June 30, 2026, driven by healthy expansion within the existing customer base, growth in new annual contract value contributions and the addition of SessionM. Adjusted EBITDA of ₹ 440.2 Million for the quarter ended June 30, 2026 registered a year-on-year growth of 132%. Normalized Profit after tax of ₹ 254.4 Million for the quarter ended June 30, 2026 also grew exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.